A detailed history of Constant Guidance Financial LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Constant Guidance Financial LLC holds 24,580 shares of BMY stock, worth $1.01 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares
24,580
Holding current value
$1.01 Million
% of portfolio
1.16%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$47.98 - $54.4 $1.18 Million - $1.34 Million
24,580 New
24,580 $1.26 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $87.4B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Constant Guidance Financial LLC Portfolio

Follow Constant Guidance Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Constant Guidance Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Constant Guidance Financial LLC with notifications on news.